CILP2 and adrenal cortex carcinoma: Our findings showed that high expression levels of CILP2 were associated with poor prognoses in all cancer types, especially in adenoid cystic carcinoma (ACC) and kidney renal clear cell carcinoma (KIRC) (Figure 2B).